Company · CIK 0001001233 · SIC 2836 — Biological Products, (No Diagnostic Substances) · OTC
SANGAMO THERAPEUTICS, INC · SGMO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2017 MForm 4 → | Nov 21, 5:01 pm EST | Saira RamasastryDirector | 5,000 | $5.03 | $25,150 | 5,000 | — | plan? |
| Oct 2, 2017 SForm 4 → | Oct 4, 4:22 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 15,000 | $15.25 | $228,754 | 15,833 | −48.6% | plan? |
| Oct 2, 2017 MForm 4 → | Oct 4, 4:22 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 15,000 | $7.66 | $114,905 | 19,587 | — | plan? |
| Sep 20, 2017 SForm 4 → | Sep 22, 4:04 pm EDT | William R RingoDirector | 31,000 | $14.37 | $445,597 | 800 | −97.5% | plan? |
| Sep 20, 2017 MForm 4 → | Sep 22, 4:04 pm EDT | William R RingoDirector | 31,000 | $6.05 | $187,550 | 31,800 | — | plan? |
| Sep 1, 2017 MForm 4 → | Sep 1, 6:19 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 10,316 | $5.41 | $55,810 | 26,149 | — | plan? |
| Sep 1, 2017 SForm 4 → | Sep 1, 6:19 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 15,000 | $15.00 | $225,000 | 15,833 | −48.6% | plan? |
| Aug 11, 2017 SForm 4 → | Aug 15, 5:31 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 11,474 | $10.44 | $119,740 | 20,517 | −35.9% | plan? |
| Aug 11, 2017 MForm 4 → | Aug 15, 5:31 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 11,474 | $4.11 | $47,111 | 25,517 | — | plan? |
| Jul 14, 2017 SForm 4 → | Jul 14, 8:06 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 15,000 | $10.00 | $150,000 | 20,517 | −42.2% | plan? |
| Jul 14, 2017 MForm 4 → | Jul 14, 8:06 pm EDT | Curt A. Herberts IIISr.VP & Chief Business Officer | 172 | $3.99 | $686 | 35,517 | — | plan? |
| Jun 1, 2017 SForm 4 → | Jun 2, 8:26 pm EDT | Curt A. Herberts IIISenior VP & CBO | 2,000 | $6.80 | $13,600 | 35,345 | −5.36% | plan? |
| May 11, 2017 SForm 4 → | May 15, 7:42 pm EDT | Curt A. Herberts IIISenior VP & CBO | 2,639 | $8.02 | $21,154 | 37,345 | −6.60% | plan? |
| Dec 12, 2016 GForm 5 → | Jan 13, 2017, 4:47 pm EST | Edward O Lanphier IIDirector | 30,000 | — | — | 1,252,119 | — | plan? |
| Dec 12, 2016 FForm 4 → | Dec 14, 8:11 pm EST | Curt A. Herberts IIISenior VP & CBO | 4,852 | $3.05 | $14,799 | 33,300 | — | plan? |
| Mar 11, 2016 FGForm 4 → | Jun 15, 8:22 pm EDT | Edward O Lanphier IIDirector | 142,642 | $6.23 | $527,320 | 1,175,094 | — | plan? late |
| Dec 12, 2015 FForm 4 → | Dec 14, 2016, 8:03 pm EST | Henry Ward WolffExec VP & CFO | 13,778 | $3.05 | $42,023 | 206,829 | — | plan? late |
| Dec 11, 2015 FForm 4 → | Dec 15, 5:12 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 8,348 | $8.68 | $72,461 | 107,328 | — | plan? |
| Dec 11, 2015 FForm 4 → | Dec 15, 5:11 pm EST | Edward O Lanphier IIPresident & CEO, Director | 34,786 | $8.68 | $301,942 | 293,906 | — | plan? |
| Dec 11, 2015 FForm 4 → | Dec 15, 5:11 pm EST | Geoffrey NicholExecutive Vice President, R&D | 9,081 | $8.68 | $78,823 | 159,676 | — | plan? |
| Dec 11, 2015 FForm 4 → | Dec 15, 5:09 pm EST | Henry Ward WolffExec VP & CFO | 12,609 | $8.68 | $109,446 | 215,703 | — | plan? |
| Dec 7, 2015 AFForm 4 → | Dec 9, 4:53 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 31,087 | $9.69 | $58,983 | 115,676 | — | plan? |
| Dec 7, 2015 AFGForm 4 → | Dec 9, 4:51 pm EST | Edward O Lanphier IIPresident & CEO, Director | 169,308 | $9.69 | $303,375 | 1,172,521 | — | plan? |
| Dec 7, 2015 AFForm 4 → | Dec 9, 4:50 pm EST | Geoffrey NicholExecutive Vice President, R&D | 44,389 | $9.69 | $66,754 | 168,757 | — | plan? |
| Dec 7, 2015 AFForm 4 → | Dec 9, 4:47 pm EST | Henry Ward WolffExec VP & CFO | 44,560 | $9.69 | $68,411 | 228,312 | — | plan? |
| Jul 15, 2015 SForm 4 → | Jul 17, 4:49 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $10.43 | $260,770 | 235,000 | −9.62% | plan? |
| Jul 15, 2015 MForm 4 → | Jul 17, 4:49 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $6.82 | $170,500 | 260,000 | — | plan? |
| Jul 10, 2015 SForm 4 → | Jul 14, 4:46 pm EDT | Henry Ward WolffExec VP & CFO | 12,000 | $10.00 | $120,000 | 197,872 | −5.72% | plan? |
| Jul 10, 2015 MForm 4 → | Jul 14, 4:46 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | $3.45 | $34,500 | 203,770 | — | plan? |
| Jun 15, 2015 SForm 4 → | Jun 17, 4:47 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $11.08 | $277,078 | 235,000 | −9.62% | plan? |
| Jun 15, 2015 MForm 4 → | Jun 17, 4:47 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $6.82 | $170,500 | 260,000 | — | plan? |
| Jun 10, 2015 SForm 4 → | Jun 12, 4:50 pm EDT | Henry Ward WolffExec VP & CFO | 12,000 | $12.21 | $146,558 | 199,872 | −5.66% | plan? |
| Jun 10, 2015 MForm 4 → | Jun 12, 4:50 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | $3.45 | $34,500 | 211,872 | — | plan? |
| Jun 5, 2015 SForm 4 → | Jun 9, 5:26 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $12.29 | $184,394 | 96,763 | −13.4% | plan? |
| Jun 5, 2015 MForm 4 → | Jun 9, 5:26 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $3.45 | $51,750 | 111,763 | — | plan? |
| Jun 3, 2015 SForm 4 → | Jun 3, 9:07 pm EDT | William R RingoDirector | 2,200 | $12.44 | $27,364 | 800 | −73.3% | plan? |
| Jun 3, 2015 MForm 4 → | Jun 3, 9:07 pm EDT | William R RingoDirector | 2,200 | $6.05 | $13,310 | 3,000 | — | plan? |
| Jun 1, 2015 SForm 4 → | Jun 3, 9:06 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | $12.39 | $185,816 | 116,410 | −11.4% | plan? |
| Jun 1, 2015 MForm 4 → | Jun 3, 9:06 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | $5.13 | $77,000 | 131,410 | — | plan? |
| May 15, 2015 SForm 4 → | May 19, 5:26 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $11.51 | $287,863 | 235,000 | −9.62% | plan? |
| May 15, 2015 MForm 4 → | May 19, 5:26 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $6.82 | $170,500 | 260,000 | — | plan? |
| May 11, 2015 SForm 4 → | May 13, 4:40 pm EDT | Henry Ward WolffExec VP & CFO | 12,000 | $13.25 | $158,949 | 201,872 | −5.61% | plan? |
| May 11, 2015 MForm 4 → | May 13, 4:40 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | $3.45 | $34,500 | 213,872 | — | plan? |
| May 5, 2015 SForm 4 → | May 5, 7:26 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $12.29 | $184,298 | 95,376 | −13.6% | plan? |
| May 5, 2015 MForm 4 → | May 5, 7:26 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $3.45 | $51,750 | 110,376 | — | plan? |
| May 4, 2015 SForm 4 → | May 5, 7:23 pm EDT | William R RingoDirector | 3,000 | $12.98 | $38,927 | 800 | −78.9% | plan? |
| May 4, 2015 MForm 4 → | May 5, 7:23 pm EDT | William R RingoDirector | 3,000 | $6.19 | $18,582 | 3,800 | — | plan? |
| May 1, 2015 SForm 4 → | May 5, 7:05 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | $12.62 | $189,371 | 116,410 | −11.4% | plan? |
| May 1, 2015 MForm 4 → | May 5, 7:05 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | $5.13 | $77,000 | 131,410 | — | plan? |
| Apr 15, 2015 SForm 4 → | Apr 17, 7:03 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $15.33 | $383,260 | 235,000 | −9.62% | plan? |
| Apr 15, 2015 MForm 4 → | Apr 17, 7:03 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $6.82 | $170,500 | 260,000 | — | plan? |
| Apr 10, 2015 SForm 4 → | Apr 14, 7:03 pm EDT | Henry Ward WolffExec VP & CFO | 12,000 | $15.31 | $183,771 | 202,849 | −5.59% | plan? |
| Apr 10, 2015 MForm 4 → | Apr 14, 7:03 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | $3.45 | $34,500 | 214,849 | — | plan? |
| Apr 6, 2015 SForm 4 → | Apr 8, 7:06 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $14.94 | $224,172 | 95,376 | −13.6% | plan? |
| Apr 6, 2015 MForm 4 → | Apr 8, 7:06 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $3.45 | $51,750 | 110,376 | — | plan? |
| Apr 6, 2015 SForm 4 → | Apr 8, 7:05 pm EDT | William R RingoDirector | 2,200 | $14.95 | $32,881 | 800 | −73.3% | plan? |
| Apr 6, 2015 MForm 4 → | Apr 8, 7:05 pm EDT | William R RingoDirector | 2,200 | $6.41 | $14,102 | 3,000 | — | plan? |
| Apr 1, 2015 SForm 4 → | Apr 3, 7:53 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | $15.15 | $227,192 | 116,410 | −11.4% | plan? |
| Apr 1, 2015 MForm 4 → | Apr 3, 7:53 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | $5.13 | $77,000 | 131,410 | — | plan? |
| Mar 19, 2015 SForm 4 → | Mar 20, 7:28 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | $18.00 | $180,000 | 204,849 | −4.65% | plan? |
| Mar 19, 2015 MForm 4 → | Mar 20, 7:28 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | $14.27 | $142,700 | 214,849 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 8:02 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $17.29 | $432,305 | 235,000 | −9.62% | plan? |
| Mar 16, 2015 GMForm 4 → | Mar 18, 8:02 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 28,500 | $6.82 | $170,500 | 1,185,521 | — | plan? |
| Mar 10, 2015 SForm 4 → | Mar 12, 8:09 pm EDT | Henry Ward WolffExec VP & CFO | 12,000 | $16.68 | $200,201 | 204,849 | −5.53% | plan? |
| Mar 10, 2015 MForm 4 → | Mar 12, 8:09 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | $3.45 | $34,500 | 216,849 | — | plan? |
| Mar 5, 2015 SForm 4 → | Mar 6, 6:51 pm EST | Steven J MentoDirector | 6,501 | $18.30 | $118,939 | 12,270 | −34.6% | plan? |
| Mar 5, 2015 MForm 4 → | Mar 6, 6:51 pm EST | Steven J MentoDirector | 10,000 | $4.54 | $45,400 | 18,771 | — | plan? |
| Mar 5, 2015 SForm 4 → | Mar 6, 6:49 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $18.29 | $274,283 | 95,376 | −13.6% | plan? |
| Mar 5, 2015 MForm 4 → | Mar 6, 6:49 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $3.45 | $51,750 | 110,376 | — | plan? |
| Mar 4, 2015 SForm 4 → | Mar 6, 7:04 pm EST | Henry Ward WolffExec VP & CFO | 10,000 | $18.00 | $180,000 | 206,849 | −4.61% | plan? |
| Mar 4, 2015 MForm 4 → | Mar 6, 7:04 pm EST | Henry Ward WolffExec VP & CFO | 10,000 | $14.27 | $142,700 | 216,849 | — | plan? |
| Mar 3, 2015 SForm 4 → | Mar 4, 8:06 pm EST | William R RingoDirector | 2,200 | $17.21 | $37,862 | 800 | −73.3% | plan? |
| Mar 3, 2015 MForm 4 → | Mar 4, 8:06 pm EST | William R RingoDirector | 2,200 | $6.41 | $14,102 | 3,000 | — | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 8:04 pm EST | Philip D GregorySVP of Research & CSO | 15,000 | $17.26 | $258,938 | 116,410 | −11.4% | plan? |
| Mar 2, 2015 MForm 4 → | Mar 4, 8:04 pm EST | Philip D GregorySVP of Research & CSO | 15,000 | $7.34 | $110,120 | 131,410 | — | plan? |
| Feb 17, 2015 SForm 4 → | Feb 19, 8:05 pm EST | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $15.69 | $392,150 | 235,000 | −9.62% | plan? |
| Feb 17, 2015 MForm 4 → | Feb 19, 8:05 pm EST | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $6.82 | $170,500 | 260,000 | — | plan? |
| Feb 12, 2015 SForm 4 → | Feb 13, 7:45 pm EST | Saira RamasastryDirector | 10,000 | $15.00 | $150,000 | 0 | −100% | plan? |
| Feb 12, 2015 MForm 4 → | Feb 13, 7:45 pm EST | Saira RamasastryDirector | 10,000 | $5.03 | $50,300 | 10,000 | — | plan? |
| Feb 10, 2015 SForm 4 → | Feb 12, 8:14 pm EST | Henry Ward WolffExec VP & CFO | 12,000 | $12.65 | $151,750 | 206,849 | −5.48% | plan? |
| Feb 10, 2015 MForm 4 → | Feb 12, 8:14 pm EST | Henry Ward WolffExec VP & CFO | 10,000 | $3.45 | $34,500 | 218,849 | — | plan? |
| Feb 5, 2015 SForm 4 → | Feb 6, 7:50 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $12.93 | $193,950 | 95,376 | −13.6% | plan? |
| Feb 5, 2015 MForm 4 → | Feb 6, 7:50 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $6.10 | $91,509 | 110,376 | — | plan? |
| Feb 3, 2015 SForm 4 → | Feb 5, 8:19 pm EST | William R RingoDirector | 2,200 | $12.70 | $27,940 | 800 | −73.3% | plan? |
| Feb 3, 2015 MForm 4 → | Feb 5, 8:19 pm EST | William R RingoDirector | 2,200 | $6.41 | $14,102 | 3,000 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 7:31 pm EST | Philip D GregorySVP of Research & CSO | 15,000 | $12.86 | $192,830 | 116,410 | −11.4% | plan? |
| Feb 2, 2015 MForm 4 → | Feb 4, 7:31 pm EST | Philip D GregorySVP of Research & CSO | 15,000 | $5.13 | $77,000 | 131,410 | — | plan? |
| Jan 15, 2015 SForm 4 → | Jan 16, 8:20 pm EST | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $14.22 | $355,622 | 235,000 | −9.62% | plan? |
| Jan 15, 2015 MForm 4 → | Jan 16, 8:20 pm EST | Edward O Lanphier IIPresident & CEO, Director | 25,000 | $6.82 | $170,500 | 245,000 | — | plan? |
| Jan 12, 2015 SForm 4 → | Jan 14, 7:02 pm EST | Henry Ward WolffExec VP & CFO | 12,000 | $15.87 | $190,450 | 208,849 | −5.43% | plan? |
| Jan 12, 2015 MForm 4 → | Jan 14, 7:02 pm EST | Henry Ward WolffExec VP & CFO | 10,000 | $3.45 | $34,500 | 220,849 | — | plan? |
| Jan 5, 2015 SForm 4 → | Jan 6, 7:27 pm EST | William R RingoDirector | 2,200 | $15.20 | $33,430 | 800 | −73.3% | plan? |
| Jan 5, 2015 MForm 4 → | Jan 6, 7:27 pm EST | William R RingoDirector | 2,200 | $6.41 | $14,102 | 3,000 | — | plan? |
| Jan 5, 2015 SForm 4 → | Jan 6, 7:26 pm EST | John William LarsonDirector | 15,000 | $15.10 | $226,550 | 214,660 | −6.53% | plan? |
| Jan 5, 2015 MForm 4 → | Jan 6, 7:26 pm EST | John William LarsonDirector | 15,000 | $6.86 | $102,850 | 229,660 | — | plan? |
| Jan 5, 2015 SForm 4 → | Jan 6, 7:24 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $15.19 | $227,854 | 95,376 | −13.6% | plan? |
| Jan 5, 2015 MForm 4 → | Jan 6, 7:24 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | $6.82 | $102,300 | 110,376 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 7:25 pm EST | Philip D GregorySVP, Research & CSO | 15,000 | $15.78 | $236,664 | 116,410 | −11.4% | plan? |
| Jan 2, 2015 MForm 4 → | Jan 6, 7:25 pm EST | Philip D GregorySVP, Research & CSO | 15,000 | $7.34 | $110,120 | 131,410 | — | plan? |
| Jul 17, 2014 PForm 4 → | Feb 18, 2015, 9:54 pm EST | RA CAPITAL MANAGEMENT, LLC +2Other | 37,215 | $12.26 | $456,211 | 2,199,753 | +1.72% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2015 MForm 4 → | Jun 3, 9:06 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | — | — | 24,172 | — | |
| May 15, 2015 MForm 4 → | May 19, 5:26 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | — | — | 75,000 | — | |
| May 11, 2015 MForm 4 → | May 13, 4:40 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | — | — | 132,000 | — | |
| May 5, 2015 MForm 4 → | May 5, 7:26 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | — | — | 65,798 | — | |
| May 4, 2015 MForm 4 → | May 5, 7:23 pm EDT | William R RingoDirector | 3,000 | — | — | 33,200 | — | |
| May 1, 2015 MForm 4 → | May 5, 7:05 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | — | — | 31,172 | — | |
| Apr 15, 2015 MForm 4 → | Apr 17, 7:03 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | — | — | 100,000 | — | |
| Apr 10, 2015 MForm 4 → | Apr 14, 7:03 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | — | — | 142,000 | — | |
| Apr 6, 2015 MForm 4 → | Apr 8, 7:06 pm EDT | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | — | — | 80,798 | — | |
| Apr 6, 2015 MForm 4 → | Apr 8, 7:05 pm EDT | William R RingoDirector | 2,200 | — | — | 1,200 | — | |
| Apr 1, 2015 MForm 4 → | Apr 3, 7:53 pm EDT | Philip D GregorySVP of Research & CSO | 15,000 | — | — | 38,172 | — | |
| Mar 19, 2015 MForm 4 → | Mar 20, 7:28 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | — | — | 251,972 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 8:02 pm EDT | Edward O Lanphier IIPresident & CEO, Director | 25,000 | — | — | 125,000 | — | |
| Mar 10, 2015 MForm 4 → | Mar 12, 8:09 pm EDT | Henry Ward WolffExec VP & CFO | 10,000 | — | — | 152,000 | — | |
| Mar 5, 2015 MForm 4 → | Mar 6, 6:51 pm EST | Steven J MentoDirector | 10,000 | — | — | 0 | — | |
| Mar 5, 2015 MForm 4 → | Mar 6, 6:49 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | — | — | 95,798 | — | |
| Mar 4, 2015 MForm 4 → | Mar 6, 7:04 pm EST | Henry Ward WolffExec VP & CFO | 10,000 | — | — | 261,972 | — | |
| Mar 3, 2015 MForm 4 → | Mar 4, 8:06 pm EST | William R RingoDirector | 2,200 | — | — | 3,400 | — | |
| Mar 2, 2015 MForm 4 → | Mar 4, 8:04 pm EST | Philip D GregorySVP of Research & CSO | 15,000 | — | — | 45,172 | — | |
| Feb 17, 2015 MForm 4 → | Feb 19, 8:05 pm EST | Edward O Lanphier IIPresident & CEO, Director | 25,000 | — | — | 150,000 | — | |
| Feb 12, 2015 MForm 4 → | Feb 13, 7:45 pm EST | Saira RamasastryDirector | 10,000 | — | — | 14,450 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 8:14 pm EST | Henry Ward WolffExec VP & CFO | 10,000 | — | — | 162,000 | — | |
| Feb 5, 2015 MForm 4 → | Feb 6, 7:50 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 15,000 | — | — | 110,798 | — | |
| Feb 3, 2015 MForm 4 → | Feb 5, 8:19 pm EST | William R RingoDirector | 2,200 | — | — | 5,600 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 7:31 pm EST | Philip D GregorySVP of Research & CSO | 15,000 | — | — | 48,172 | — | |
| Jan 15, 2015 MForm 4 → | Jan 16, 8:20 pm EST | Edward O Lanphier IIPresident & CEO, Director | 25,000 | — | — | 175,000 | — | |
| Jan 12, 2015 MForm 4 → | Jan 14, 7:02 pm EST | Henry Ward WolffExec VP & CFO | 10,000 | — | — | 172,000 | — | |
| Jan 5, 2015 MForm 4 → | Jan 6, 7:27 pm EST | William R RingoDirector | 2,200 | — | — | 7,800 | — | |
| Jan 5, 2015 MForm 4 → | Jan 6, 7:26 pm EST | John William LarsonDirector | 15,000 | — | — | 0 | — | |
| Jan 5, 2015 MForm 4 → | Jan 6, 7:24 pm EST | Dale G AndoVP, Therapeutic Dev. & CMO | 1,500 | — | — | 11,798 | — | |
| Jan 2, 2015 MForm 4 → | Jan 6, 7:25 pm EST | Philip D GregorySVP, Research & CSO | 15,000 | — | — | 78,000 | — | |
| Jan 29, 2014 PSForm 4 → | Feb 18, 2015, 9:49 pm EST | RA CAPITAL MANAGEMENT, LLC +2Other | 33,100 | $4.63 | $153,088 | 8,275 | — | late |